Effect of BP 2.94, a histamine H3-receptor agonist prodrug, on different models of colitis.
Coruzzi
G
G
Institute of Pharmacology, University of Parma, Italy. gabriella.coruzzi@unipr.it
Poli
E
E
Pozzoli
C
C
Nosalova
V
V
Grandi
D
D
Lazzaretti
M
M
Schunack
W
W
D019342:Acetic Acid; D000818:Animals; D003092:Colitis / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D000431:Ethanol; D017442:Histamine Agonists / Q000627:therapeutic use*; D006633:Histamine Antagonists / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007097:Imines / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D010636:Phenols / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D018100:Receptors, Histamine H3 / Q000187:drug effects; D014302:Trinitrobenzenesulfonic Acid
D017442:Histamine Agonists; D006633:Histamine Antagonists; D007093:Imidazoles; D007097:Imines; D010636:Phenols; D011355:Prodrugs; D018100:Receptors, Histamine H3; C106714:BP 2-94; D000431:Ethanol; C115705:ciproxifan; D014302:Trinitrobenzenesulfonic Acid; D019342:Acetic Acid